EBITDA Margin % is calculated as EBITDA divided by its Revenue. Zepp Health's EBITDA for the
three
months ended in Mar. 2026 was €-15.0 Mil. Zepp Health's Revenue for the
three
months ended in Mar. 2026 was €44.6 Mil. Therefore, Zepp Health's EBITDA margin for the quarter that ended in Mar. 2026 was -33.63%.
Zepp Health (FRA:ST0) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Zepp Health EBITDA Margin % Related Terms
Zepp Health EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Zepp Health's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:ST0 vs UEIC, AXIL, KOSS: EBITDA Margin % Comparison
For the Consumer Electronics subindustry, Zepp Health's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zepp Health EBITDA Margin % vs Hardware Industry
For the Hardware industry and Technology sector, Zepp Health's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Zepp Health's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zepp Health (FRA:ST0) has a EBITDA Margin % of -33.63% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Zepp Health and its competitors. According to the industry distribution chart, Zepp Health ranks #2098 out of 2472 companies in the Hardware industry, placing it in the top 84.9%.
Is Zepp Health's EBITDA Margin % too high?
Zepp Health's current EBITDA Margin % is -33.63%. Based on the distribution chart, Zepp Health ranks #2098 out of 2472 companies in the Hardware industry, which is in the bottom quartile relative to peers. Overall, Zepp Health has a GF Score™ of 40/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Zepp Health's EBITDA Margin % compare to UEIC and AXIL?
According to the Hardware industry distribution chart, Zepp Health ranks #2098 out of 2472 companies for EBITDA Margin %. This places Zepp Health in the lower half of its industry. The industry median EBITDA Margin % is 7.01. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Hardware company?
The median EBITDA Margin % among Hardware companies is 7.01, based on 2,472 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Zepp Health and its competitors. For the Hardware industry, the median EBITDA Margin % is 7.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zepp Health's current EBITDA Margin % is -33.63%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zepp Health stock overvalued right now?
Based on GuruFocus' analysis, Zepp Health (FRA:ST0) is currently considered Modestly Overvalued. The stock's GF Value™ is €3.24, compared to a current price of €3.70 — trading 14.2% above its estimated fair value. The current EBITDA Margin % is -33.63%. Zepp Health's overall GF Score™ is 40/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Zepp Health (FRA:ST0), the current EBITDA Margin % is -33.63% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zepp Health (FRA:ST0) Overvalued in 2026?
Based on GuruFocus' analysis, Zepp Health stock appears to be overvalued.
The current stock price of €3.70 is trading 14.2% above its estimated GF Value™ of €3.24.
GuruFocus considers Zepp Health to be Modestly Overvalued.
Key valuation signals for FRA:ST0:
EBITDA Margin %: -33.63%
GF Value™: €3.24 vs. price of €3.70 (14.2% above fair value)
No single metric tells the full story. See the FRA:ST0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands. Geographically, the group generates revenue from Asia-Pacific, Europe, North America and others.
40GF Score
Get the complete analysis for FRA:ST0
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:ST0 has been successfully added to your 
